1. Home
  2. BMRA vs RVYL Comparison

BMRA vs RVYL Comparison

Compare BMRA & RVYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRA
  • RVYL
  • Stock Information
  • Founded
  • BMRA 1971
  • RVYL 2007
  • Country
  • BMRA United States
  • RVYL United States
  • Employees
  • BMRA N/A
  • RVYL N/A
  • Industry
  • BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • RVYL Professional Services
  • Sector
  • BMRA Health Care
  • RVYL Consumer Discretionary
  • Exchange
  • BMRA Nasdaq
  • RVYL Nasdaq
  • Market Cap
  • BMRA 9.8M
  • RVYL 13.7M
  • IPO Year
  • BMRA N/A
  • RVYL N/A
  • Fundamental
  • Price
  • BMRA $0.37
  • RVYL $2.02
  • Analyst Decision
  • BMRA
  • RVYL Hold
  • Analyst Count
  • BMRA 0
  • RVYL 1
  • Target Price
  • BMRA N/A
  • RVYL N/A
  • AVG Volume (30 Days)
  • BMRA 98.5K
  • RVYL 46.0K
  • Earning Date
  • BMRA 08-23-2024
  • RVYL 08-12-2024
  • Dividend Yield
  • BMRA N/A
  • RVYL N/A
  • EPS Growth
  • BMRA N/A
  • RVYL N/A
  • EPS
  • BMRA N/A
  • RVYL N/A
  • Revenue
  • BMRA $5,405,208.00
  • RVYL $71,352,000.00
  • Revenue This Year
  • BMRA N/A
  • RVYL $31.47
  • Revenue Next Year
  • BMRA N/A
  • RVYL N/A
  • P/E Ratio
  • BMRA N/A
  • RVYL N/A
  • Revenue Growth
  • BMRA N/A
  • RVYL 78.42
  • 52 Week Low
  • BMRA $0.28
  • RVYL $1.12
  • 52 Week High
  • BMRA $2.13
  • RVYL $17.50
  • Technical
  • Relative Strength Index (RSI)
  • BMRA 25.08
  • RVYL 59.40
  • Support Level
  • BMRA $0.28
  • RVYL $1.95
  • Resistance Level
  • BMRA $0.51
  • RVYL $2.25
  • Average True Range (ATR)
  • BMRA 0.04
  • RVYL 0.21
  • MACD
  • BMRA -0.00
  • RVYL 0.05
  • Stochastic Oscillator
  • BMRA 44.95
  • RVYL 63.11

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.

About RVYL Ryvyl Inc.

Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.

Share on Social Networks: